-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GAUaNrryHgKGPSqleCs5eFXNThgOMQHBTsxq0tck26CpBISlkOP/p/XY2GtxuZD2 3CNhVxsyZl3TvHp9XjoPHg== 0001225208-09-020866.txt : 20091023 0001225208-09-020866.hdr.sgml : 20091023 20091023161941 ACCESSION NUMBER: 0001225208-09-020866 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091021 FILED AS OF DATE: 20091023 DATE AS OF CHANGE: 20091023 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 5086508000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NICHOLAS PETER M CENTRAL INDEX KEY: 0000901458 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 091134806 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORPORATION STREET 2: ONE BOSTON SCIENTIFIC PLACE CITY: NATICK STATE: MA ZIP: 01760-1537 4 1 doc4.xml X0303 4 2009-10-21 0000885725 BOSTON SCIENTIFIC CORP BSX 0000901458 NICHOLAS PETER M ONE BOSTON SCIENTIFIC PLACE NATICK MA 01760-1537 1 Common Stock 2009-10-21 4 S 0 50000 8.3529 D 10448610 D Common Stock 2009-10-21 4 S 0 50000 8.3529 D 12428087 I By Ltd. Partnership Common Stock 2413088 I By Trust 2 Forward Sale Contract (obligation to sell) 0 2009-10-21 4 J 0 50000 0 A 2010-10-21 2010-10-21 Common Stock 50000 50000 I By Ltd. Partnership Sales reported on this form were transacted pursuant to a 10b5-1 trading plan. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $8.46 to $8.20. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. Shares held by a trust of which the reporting person's spouse and brother are trustees and the reporting person's spouse and children are beneficiaries. On August 26, 2009, a family limited partnership of which the reporting person is a general and limited partner, Promerica L.P., entered into a Rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. Under the contract reported on this form, Promerica will deliver to the bank up to 50,000 shares of the Issuer's common stock depending on market prices at maturity on October 21, 2010. If the market price per share at maturity is equal to or less than the floor price of $8.3147 per share, Promerica will deliver 50,000 shares to the bank. If the market price per share at maturity is greater than the floor price, Promerica will deliver a fewer number of shares. In exchange, the bank is obligated to pay $332,588.00 to Promerica two business days after the date of the contract. At the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock. Promerica pledged 50,000 shares of the Issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge. The reporting person disclaims beneficial ownership of this stock except to the extent of his pecuniary interest. /s/ Lawrence J. Knopf, Attorney-in-fact 2009-10-23 -----END PRIVACY-ENHANCED MESSAGE-----